Clinical Trial Update: Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating the combination of HX008 and niraparib for germline mutation-associated metastatic breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HX008
• Niraparib (Niraparib)

Snippet

Sponsor: Fudan University | Conditions: Treatment Efficacy | Phase 2 | Status: COMPLETED